US$ 27.85
glp-1/gip/glucagon receptor agonist Schematic illustration of monoagonists, dual agonists and triple Eat Less & Burn More
Description
10.1056/NEJMoa2401943

Once-Weekly Semaglutide in Adolescents with Obesity. The New England Journal of Medicine, vol

Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: An implication in the treatment of atherosclerosis

Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity

Coverage for obesity indications (Wegovy, Saxenda, Zepbound) remains more limited
An athlete needing dialysis treatment requires a Therapeutic Use Exemption
